蘇寧易購(002024.SZ)今復牌 擬引進戰略股東深圳國際(00152.HK)
蘇寧易購(002024.SZ)公布,公司控股股東、實際控制人張近東擬將所持公司23%股份,轉讓給深圳國際(00152.HK)及鯤鵬資本或鯤鵬資本指定投資主體,如此次股份轉讓事項實施完畢,公司將處於無控股股東、無實際控制人狀態。
此次股份轉讓完成後,深圳國際、鯤鵬資本作為公司的產業投資人,將與其他相關方共同圍繞商品供應鏈、電商、科技、物流、免稅業務等領域,對公司進行綜合賦能;推動相關方為公司及其業務發展提供必要的政策、稅收、金融等方面的支持;公司將在深圳設立華南地區總部,全面提升公司在華南地區尤其是在大灣區的經營能力及企業品牌知名度,有效提升市場佔有率。
蘇寧易購將於今早起復牌。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.